Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin

Conclusions: Abnormalities in albumin and prealbumin levels are common among COVID-19 patients and hypoprealbuminemia independently predicts adverse outcome and should be carefully considered in clinical practice. Moreover, changes in liver-related biomarkers is not a salient feature of COVID-19.
Source: The Saudi Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research